EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Association between Group B Streptococcus and Clinical Chorioamnionitis by Gestational Week at Delivery—A Multicenter Cohort Study

Jennifer A McCoy iD, Tzuria Peled, Ari Weiss, Lisa D Levine, Sorina Grisaru-Granovsky, Misgav Rottenstreich iD

American Journal of Perinatology · 01.01.2025 · 42 (02) · 181-188

DOI: 10.1055/a-2334-7088 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.01.2025. Verfasst von Jennifer A McCoy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Maternal Fetal Medicine Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelp…. Hauptthemen laut MEDLINE: Chorioamnionitis, Gestational Age, Pregnancy Complications, Infectious, Streptococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In the era of group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis (IAP), GBS colonization has been associated with a lower risk of chorioamnionitis, possibly due to a protective effect of IAP. We sought to confirm this finding and assess whether this association varies by gestational week at delivery. Study Design We performed a retrospective cohort study of term (37.0–42.6 weeks), singleton parturients with known GBS status who delivered from 2005 to 2021 at two academic medical centers in Israel. We excluded patients who underwent planned cesarean, out of hospital birth, or had a fetal demise. Patients received GBS screening and IAP for GBS positivity as routine clinical care. The primary outcome was a diagnosis of clinical chorioamnionitis as determined by the International Classification of Diseases 10th Revision code, compared between GBS-positive and -negative groups, and assessed by gestational week at delivery.

Results

Of 292,126 deliveries, 155,255 met inclusion criteria. In total, 30.1% were GBS positive and 69.9% were negative. GBS-positive patients were 21% less likely to be diagnosed with clinical chorioamnionitis than GBS-negative patients, even after controlling for confounders (1.5 vs. 2.2%, adjusted odds ratio: 0.79, 95% confidence interval: 0.68–0.92). When assessed by gestational week at delivery, there was a significantly greater difference in rates of clinical chorioamnionitis between GBS-positive versus GBS-negative groups with advancing gestational age: 1.5-fold difference at 38 to 40 weeks, but a twofold difference at 42 weeks. The risk of clinical chorioamnionitis remained stable in the GBS-positive group, but increased significantly in the GBS-negative group at 41- and 42-week gestation (2.0 vs. 2.9%, p < 0.01 at 41 weeks; up to 3.9% at 42 weeks, p < 0.01).

Conclusion

In a large multicenter cohort with universal GBS screening and IAP, GBS positivity was associated with a lower risk of chorioamnionitis, driven by an increasing rate of chorioamnionitis among GBS-negative patients after 40 weeks. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChorioamnionitisGestational AgePregnancy Complications, InfectiousStreptococcal InfectionsStreptococcus agalactiaeDelivery, ObstetricAdultFemaleHumansPregnancyAntibiotic ProphylaxisIsraelRetrospective StudiesCohort Studies

Autor:innen und Institutionen

  • Maternal Fetal Medicine Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.
  • Department of Nursing, Jerusalem College of Technology, Jerusalem, Israel.

ORCID-Profile: Jennifer A McCoy, Misgav Rottenstreich

Förderung

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

McCoy, J. A., Peled, T., Weiss, A., Levine, L. D., Grisaru-Granovsky, S., & Rottenstreich, M. (2025). Association between Group B Streptococcus and Clinical Chorioamnionitis by Gestational Week at Delivery—A Multicenter Cohort Study. American Journal of Perinatology, 42(02), 181-188. https://doi.org/10.1055/a-2334-7088

Vancouver

McCoy JA, Peled T, Weiss A, Levine LD, Grisaru-Granovsky S, Rottenstreich M. Association between Group B Streptococcus and Clinical Chorioamnionitis by Gestational Week at Delivery—A Multicenter Cohort Study. American Journal of Perinatology. 2025;42(02):181-188. doi:10.1055/a-2334-7088

BibTeX
@article{McCoy2025,
  author = {McCoy, Jennifer A and Peled, Tzuria and Weiss, Ari and Levine, Lisa D and Grisaru-Granovsky, Sorina and Rottenstreich, Misgav},
  title = {Association between Group B Streptococcus and Clinical Chorioamnionitis by Gestational Week at Delivery—A Multicenter Cohort Study},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {02},
  pages = {181--188},
  doi = {10.1055/a-2334-7088}
}
Kostenlos starten →